i.
Factor V Lieden, Prothrombin gene mutation, lupus anticoagulant,
Protein C & S, homocysteine levels
|
ii.
Von Willebrand’s antigen, Factor VIII levels,
ristocestin cofactor activity (we do not perform multimer
analysis)
|
iii.
Platelet aggregation studies
|
iv.
Platelet function analysis (PFA) to evaluate for von-Willebrand
disease, aspirin effect and limited platelet function
defects
|
v.
Thrombo-elastograph studies (TEG) to evaluate the coagulation
system as a whole
|
vi.
Plavix effect studies by Accumetrix testing
|